Donate Help Contact The AHA Sign In Home
American Heart Association
Hypertension
Search: search_blue_button Advanced Search
Published Online
on November 29, 2004

Hypertension. 2004
Published online before print November 29, 2004, doi: 10.1161/01.HYP.0000150161.78556.c6
A more recent version of this article appeared on January 1, 2005
This Article
Right arrow Full Text (PDF)
Right arrow All Versions of this Article:
45/1/115    most recent
01.HYP.0000150161.78556.c6v1
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrowRequest Permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Vázquez, J.
Right arrow Articles by Raizada, M. K.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Vázquez, J.
Right arrow Articles by Raizada, M. K.
Related Collections
Right arrow ACE/Angiotension receptors
Right arrow Other hypertension
Right arrow Functional genomics
Right arrow Hypertension - basic studies
Right arrow Gene therapy

Submitted on July 22, 2004
Revised on August 19, 2004

Selective Silencing of Angiotensin Receptor Subtype 1a (AT1aR) by RNA Interference

Jorge Vázquez; María F. Correa de Adjounian; Colin Sumners; Aaron González; Carlos Diez-Freire; and Mohan K. Raizada*

From the Department of Physiology and Functional Genomics (J.V., C.S., A.G., C.D.-F., M.K.R.), University of Florida College of Medicine and McKnight Brain Institute, Gainesville, Fla; and the Instituto de Medicina Experimental (M.F.C.d.A.), Universidad Central de Venezuela, Caracas, Venezuela.

* To whom correspondence should be addressed. E-mail: mraizada{at}phys.med.ufl.edu.

Abstract--Angiotensin II exerts its physiological effects by activating multiple subtypes of its receptor such as AT1a-, AT1b-, and AT2-receptors. Because of a high degree of similarity among these G-protein-coupled receptors, it has been difficult to assign diverse physiological actions of angiotensin II through these receptor subtypes. We have developed small interfering RNAs to selectively inhibit the expression of the AT1a receptor (AT1aR) subtype. A dsRNA, AT1 47, was found to be highly selective and efficient in reducing the levels of AT1aR subtype. Transfection of AT1aR-expressing CHO cells with dsRNA AT1 47 resulted in an 80% decrease in the AT1aR expression. In contrast, dsRNA AT1 47 showed no significant effects on both AT1bR and AT2R subtypes. Thus, AT1 47 provides us with a powerful tool to selectively silence this subtype of receptor to investigate its role in cardiovascular physiology.


Key words: receptors, angiotensin II • gene therapy • receptors, angiotensin




This article has been cited by other articles:


Home page
Am. J. Physiol. Renal Physiol.Home page
X. C. Li, O. A. Carretero, L. G. Navar, and J. L. Zhuo
AT1 receptor-mediated accumulation of extracellular angiotensin II in proximal tubule cells: role of cytoskeleton microtubules and tyrosine phosphatases
Am J Physiol Renal Physiol, August 1, 2006; 291(2): F375 - F383.
[Abstract] [Full Text] [PDF]


Home page
HypertensionHome page
Y. Chen, H. Chen, A. Hoffmann, D. R. Cool, D. I. Diz, M. C. Chappell, A. Chen, and M. Morris
Adenovirus-Mediated Small-Interference RNA for In Vivo Silencing of Angiotensin AT1a Receptors in Mouse Brain
Hypertension, February 1, 2006; 47(2): 230 - 237.
[Abstract] [Full Text] [PDF]